vs
达尔科技（DIOD）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是达尔科技的1.6倍（$622.0M vs $391.6M），Royalty Pharma plc净利率更高（34.4% vs 2.6%，领先31.8%），达尔科技同比增速更快（15.4% vs 4.8%），过去两年达尔科技的营收复合增速更高（13.9% vs 4.6%）
达尔科技是一家全球性半导体制造商，主营分立器件、模拟及混合信号半导体产品的设计、生产与销售，产品广泛应用于汽车、工业、消费电子、计算及通信基础设施等核心领域，服务全球各地客户。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
DIOD vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.6倍
$391.6M
营收增速更快
DIOD
高出10.6%
4.8%
净利率更高
RPRX
高出31.8%
2.6%
两年增速更快
DIOD
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $391.6M | $622.0M |
| 净利润 | $10.2M | $214.2M |
| 毛利率 | 31.1% | — |
| 营业利润率 | 3.4% | 62.4% |
| 净利率 | 2.6% | 34.4% |
| 营收同比 | 15.4% | 4.8% |
| 净利润同比 | 23.8% | 2.9% |
| 每股收益（稀释后） | $0.23 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DIODRPRX
| Q4 25 | $391.6M | $622.0M | ||
| Q3 25 | $392.2M | $609.3M | ||
| Q2 25 | $366.2M | $578.7M | ||
| Q1 25 | $332.1M | $568.2M | ||
| Q4 24 | $339.3M | $593.6M | ||
| Q3 24 | $350.1M | $564.7M | ||
| Q2 24 | $319.8M | $537.3M | ||
| Q1 24 | $302.0M | $568.0M |
净利润DIODRPRX
| Q4 25 | $10.2M | $214.2M | ||
| Q3 25 | $14.3M | $288.2M | ||
| Q2 25 | $46.1M | $30.2M | ||
| Q1 25 | $-4.4M | $238.3M | ||
| Q4 24 | $8.2M | $208.2M | ||
| Q3 24 | $13.7M | $544.0M | ||
| Q2 24 | $8.0M | $102.0M | ||
| Q1 24 | $14.0M | $4.8M |
毛利率DIODRPRX
| Q4 25 | 31.1% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 31.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 33.7% | — | ||
| Q2 24 | 33.6% | — | ||
| Q1 24 | 33.0% | — |
营业利润率DIODRPRX
| Q4 25 | 3.4% | 62.4% | ||
| Q3 25 | 3.0% | 70.1% | ||
| Q2 25 | 2.6% | 36.3% | ||
| Q1 25 | 0.4% | 94.0% | ||
| Q4 24 | 3.5% | 60.9% | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 1.2% | 50.2% | ||
| Q1 24 | 4.3% | -13.0% |
净利率DIODRPRX
| Q4 25 | 2.6% | 34.4% | ||
| Q3 25 | 3.6% | 47.3% | ||
| Q2 25 | 12.6% | 5.2% | ||
| Q1 25 | -1.3% | 41.9% | ||
| Q4 24 | 2.4% | 35.1% | ||
| Q3 24 | 3.9% | 96.3% | ||
| Q2 24 | 2.5% | 19.0% | ||
| Q1 24 | 4.6% | 0.8% |
每股收益（稀释后）DIODRPRX
| Q4 25 | $0.23 | $0.49 | ||
| Q3 25 | $0.31 | $0.67 | ||
| Q2 25 | $0.99 | $0.07 | ||
| Q1 25 | $-0.10 | $0.55 | ||
| Q4 24 | $0.18 | $0.46 | ||
| Q3 24 | $0.30 | $1.21 | ||
| Q2 24 | $0.17 | $0.23 | ||
| Q1 24 | $0.30 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $377.0M | $618.7M |
| 总债务越低越好 | $25.7M | $9.0B |
| 股东权益账面价值 | $1.9B | $9.7B |
| 总资产 | $2.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资DIODRPRX
| Q4 25 | $377.0M | $618.7M | ||
| Q3 25 | $386.4M | $938.9M | ||
| Q2 25 | $327.3M | $631.9M | ||
| Q1 25 | $343.9M | $1.1B | ||
| Q4 24 | $316.1M | $929.0M | ||
| Q3 24 | $319.3M | $950.1M | ||
| Q2 24 | $273.9M | $1.8B | ||
| Q1 24 | $276.0M | $843.0M |
总债务DIODRPRX
| Q4 25 | $25.7M | $9.0B | ||
| Q3 25 | $24.9M | $8.9B | ||
| Q2 25 | $26.4M | $8.0B | ||
| Q1 25 | $20.5M | $7.6B | ||
| Q4 24 | $20.7M | $7.6B | ||
| Q3 24 | $22.2M | $7.6B | ||
| Q2 24 | $20.3M | $7.6B | ||
| Q1 24 | $20.9M | $6.1B |
股东权益DIODRPRX
| Q4 25 | $1.9B | $9.7B | ||
| Q3 25 | $1.9B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $1.8B | $9.8B | ||
| Q4 24 | $1.8B | $10.3B | ||
| Q3 24 | $1.8B | $10.3B | ||
| Q2 24 | $1.8B | $9.8B | ||
| Q1 24 | $1.7B | $9.9B |
总资产DIODRPRX
| Q4 25 | $2.4B | $19.6B | ||
| Q3 25 | $2.5B | $19.3B | ||
| Q2 25 | $2.5B | $18.3B | ||
| Q1 25 | $2.4B | $17.6B | ||
| Q4 24 | $2.4B | $18.2B | ||
| Q3 24 | $2.4B | $18.0B | ||
| Q2 24 | $2.4B | $17.7B | ||
| Q1 24 | $2.4B | $16.1B |
负债/权益比DIODRPRX
| Q4 25 | 0.01× | 0.92× | ||
| Q3 25 | 0.01× | 0.93× | ||
| Q2 25 | 0.01× | 0.84× | ||
| Q1 25 | 0.01× | 0.78× | ||
| Q4 24 | 0.01× | 0.74× | ||
| Q3 24 | 0.01× | 0.74× | ||
| Q2 24 | 0.01× | 0.78× | ||
| Q1 24 | 0.01× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $12.4M | — |
| 自由现金流率自由现金流/营收 | 3.2% | — |
| 资本支出强度资本支出/营收 | 6.6% | — |
| 现金转化率经营现金流/净利润 | 3.74× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $137.2M | — |
8季度趋势，按日历期对齐
经营现金流DIODRPRX
| Q4 25 | $38.1M | $827.1M | ||
| Q3 25 | $79.1M | $702.6M | ||
| Q2 25 | $41.5M | $364.0M | ||
| Q1 25 | $56.7M | $596.1M | ||
| Q4 24 | $81.8M | $742.5M | ||
| Q3 24 | $54.4M | $703.6M | ||
| Q2 24 | $14.4M | $658.2M | ||
| Q1 24 | $-31.1M | $664.6M |
自由现金流DIODRPRX
| Q4 25 | $12.4M | — | ||
| Q3 25 | $62.8M | — | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $62.1M | — | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-51.5M | — |
自由现金流率DIODRPRX
| Q4 25 | 3.2% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 12.3% | — | ||
| Q4 24 | 18.3% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | -17.1% | — |
资本支出强度DIODRPRX
| Q4 25 | 6.6% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 5.6% | — | ||
| Q1 24 | 6.7% | — |
现金转化率DIODRPRX
| Q4 25 | 3.74× | 3.86× | ||
| Q3 25 | 5.54× | 2.44× | ||
| Q2 25 | 0.90× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 9.93× | 3.57× | ||
| Q3 24 | 3.95× | 1.29× | ||
| Q2 24 | 1.80× | 6.45× | ||
| Q1 24 | -2.22× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
